Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +4.43% | +0.35% | -75.34% |
Jun. 07 | Top Premarket Decliners | MT |
May. 10 | Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.34% | 4.52M | |
+49.42% | 779B | |
+40.67% | 631B | |
-6.14% | 354B | |
+20.97% | 333B | |
+8.70% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.73% | 163B |
- Stock Market
- Equities
- PCSA Stock
- News Processa Pharmaceuticals, Inc.
- Benchmark Adjusts Price Target on Processa Pharmaceuticals to $4 From $9, Keeps Speculative Buy Rating